left-caret
Anwaelte
Image: Nisa R Gosselink-Ulep

Nisa R Gosselink-Ulep

Of Counsel, Litigation Department
Washington, D.C.
2050 M Street NW
Washington, D.C. 20036
United States

Fax: 1(202) 551-0146

Overview

Nisa R. Gosselink-Ulep is Of Counsel in the Litigation Department of the firm's Washington, D.C. Office where her practice primarily focused on matters relating to the U.S. Foreign Corrupt Practices Act ("FCPA") and international anti-corruption law. Ms. Gosselink-Ulep has extensive experience advising multinational clients regarding anti-corruption compliance programs, risk assessments, conducting due diligence on third parties and in connection with acquisitions, and corruption-related internal investigations. In addition, she has also worked as part of independent corporate monitor teams as well as preparing clients for corporate monitors. Ms. Gosselink-Ulep counsels clients from a broad range of industries, including Defense; Life Sciences and Healthcare; Oil & Gas; Construction & Engineering; Manufacturing; Private Equity; Real Estate; Telecommunications; Non-Profits; Management Consulting; Technology; Agricultural; Retail; Education; and Entertainment, and has traveled throughout Asia, Europe, Latin America and Africa on client matters. She also has worked on matters involving export controls, international arbitration, and political risk insurance. As part of her pro bono efforts, Ms. Gosselink-Ulep has for several years co-facilitated the International Law Institute's Governance and Anti-corruption Methods course. Additionally, she acts as a mentor to student clinicians as part of the University of Michigan's International Transactions Clinic.

Accolades and Recognitions

December 2020, Paul Hastings named "Compliance Group of the Year" by Law360

October 2020, Paul Hastings named to World's Top 10 Best Investigations Practices by Global Investigations Review

May 2020, Paul Hastings wins National Law Journal's White Collar Litigation Department of the Year Award

Education

  • George Washington Law School, J.D., 2005

  • University of Hawaii, BFA, 1994

Speaking Engagements

  • July 2020, Co-Author, "Evolution not Revolution: DOJ and SEC Update The FCPA Resource Guide"

  • Facilitate and co-teach the International Law Institute's annual Government Anti-Corruption Methods course, May 2009 to present

  • Panelist, "Bribery: What is it, What should be done, and How to Comply?," Fordham Law School, International Law Weekend 2010, October 23, 2010

  • Panelist, "FCPA Compliance Tools and Techniques," State Bar of Georgia's Institute of Continuing Legal Education, Foreign Corrupt Practices Act (FCPA): International Business & Crime, September 2, 2010

Involvement

  • Supervising pro bono attorney, University of Michigan International Transactions Clinic, 2010-present

  • Paul Hastings Mentoring Committee, 2008-present

  • Paul Hastings Green Team co-chair, 2015-2018

Recent Representations

  • Represent a Fortune Global 500 pharmaceutical corporation in connection with a corruption-related investigation by multiple national enforcement agencies in various jurisdictions in Europe and Asia, and conducting a global risk assessment

  • Represent a Fortune 500 manufacturing and retail corporation in connection with a global risk assessment of its anti-corruption compliance program and internal controls

  • Represent a Fortune 150 defense contractor in connection with its anti-corruption compliance program, including risk assessments, day-to-day advice, and third-party due diligence in various jurisdictions

  • Represent leading Israeli defense contractor in connection with its anti-corruption compliance program, including development and implementation of program, training, day-to-day advice, and third-party due diligence in various jurisdictions

  • Represent a Fortune 250 engineering and construction corporation in connection with corruption-related acquisition due diligence and third-party due diligence in various jurisdictions

  • Represent a medical device company in connection with a corruption-related investigation in Europe and ongoing advice regarding its anti-corruption compliance program and relationships with third parties

  • Represent a Fortune 400 industrial equipment manufacturer in connection with anti-corruption related investigations in Asia and Europe, development of its anti-corruption compliance program, and ongoing advice

  • Represent a private equity firm in connection with anti-corruption related acquisition due diligence in multiple jurisdictions and development of an anti-corruption compliance program

  • Represent a Fortune 100 technology corporation in connection with its anti-corruption compliance program

  • Represented a U.S. subsidiary of a FTSE 250 corporation in connection with a risk assessment, enhancement of its anti-corruption compliance program, and selection of and relationship with an independent compliance monitor

  • Represented a U.S. subsidiary of a FTSE 250 corporation in connection with a risk assessment, enhancement of its anti-corruption compliance program, and selection of and relationship with an independent compliance monitor

  • Represented a global technology and business services corporation in connection with a corruption-related internal investigation of its operations in Asia, development and implementation of its anti-corruption compliance program, and third-party due diligence in various jurisdictions

  • Represented a Fortune 250 corporation in connection with anti-corruption related acquisition due diligence in Asia, South America, North America, and Europe

  • Represented a Fortune 50 pharmaceutical and healthcare corporation in connection with a risk assessment and enhancements to its anti-corruption compliance program, and periodic reports to the DOJ and SEC

  • Represented a Fortune 100 global conglomerate in connection with acquisition-related and third-party due diligence in various jurisdictions

  • Represented an internationally-renowned non-profit organization with conducting and preparing a report regarding an internal investigation

  • Represented a private equity firm in connection with a risk assessment of its operations and those of its investment companies, development of an anti-corruption compliance program, training of its employees, and day-to-day anti-corruption compliance advice

  •  Represented a Fortune 250 multi-industry corporation in connection with enhancement of its compliance program and third-party due diligence in various jurisdictions

Practice Areas

Life Sciences and Healthcare
Litigation
Political Risk and International Trade Credit Insurance
Anti-corruption and FCPA
Investigations and White Collar Defense

Languages

englisch

Admissions

District of Columbia Bar
Maryland Bar

Education

The George Washington University Law School, J.D. 2005
University of Hawaii at Manoa, B.F.A. 1994

Nehmen Sie Kontakt mit uns auf

Kontaktieren Sie uns